Palumbo Wealth Management »

Crinetics Pharmaceuticals In shares owned by Palumbo Wealth Management

Quarter-by-quarter ownership of Crinetics Pharmaceuticals In (CRNX) shares owned by Palumbo Wealth Management from 13F filings

Historical chart of Palumbo Wealth Management investment in Crinetics Pharmaceuticals In

Tip: Access up to 7 years of quarterly data

All positions including Crinetics Pharmaceuticals In held by Palumbo Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crinetics Pharmaceuticals In by Palumbo Wealth Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $270k 5.8k 46.55

More positions owned by Palumbo Wealth Management

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Apple (AAPL)
Spdr Gold Tr Gold Shs (GLD)
J P Morgan Exchange Traded F Ultra Shrt Etf (JPST)
Invesco Db Commdy Indx Trck Unit (DBC)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Waste Management (WM)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Sprott Asset Management Physical Gold Tr (PHYS)
Ishares Tr Core S&p Scp Etf (IJR)
Visa Com Cl A (V)

View all positions for Palumbo Wealth Management

Top funds holding Crinetics Pharmaceuticals In

FMR
Vanguard Group
Wellington Management Company
BlackRock
Farallon Capital Management
Driehaus Capital Management
EcoR1 Capital
Henderson Group
Point72 Asset Management
Geode Capital Management
Paradigm Biocapital Advisors
State Street Corporation
Novo A/S
Pictet Asset Management Holding SA
Siren

View all funds holding Crinetics Pharmaceuticals In